Jupiter Neurosciences Inc (JUNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 724 | 1,878 | 2,707 | 3,770 | 0 |
| Other current assets | 142 | 174 | 138 | 114 | 0 |
| TOTAL | $1,632 | $2,819 | $3,611 | $4,650 | $1 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 944 | 1,149 | 1,352 | 1,552 | 85 |
| TOTAL | $944 | $1,149 | $1,352 | $1,552 | $85 |
| Total Assets | $2,576 | $3,968 | $4,963 | $6,202 | $86 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 478 | 574 | 283 | 397 | 664 |
| Accrued Expenses | 1,853 | 1,861 | 1,410 | 1,416 | 2,202 |
| Other current liabilities | 7 | N/A | N/A | N/A | N/A |
| TOTAL | $2,519 | $2,628 | $1,890 | $2,009 | $5,681 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 9 | 21 | 156 |
| TOTAL | $N/A | $N/A | $9 | $21 | $156 |
| Total Liabilities | $2,519 | $2,628 | $1,898 | $2,030 | $5,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,426 | 34,833 | 33,104 | 33,104 | 33,104 |
| Common Shares | 3 | 4 | 3 | 3 | 3 |
| Retained earnings | -32,092 | -29,804 | -27,551 | -26,022 | -24,495 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -75 |
| TOTAL | $57 | $1,340 | $3,065 | $4,172 | $-5,751 |
| Total Liabilities And Equity | $2,576 | $3,968 | $4,963 | $6,202 | $86 |